Skip to main content

Table 1 Patient demographics and treatments pursued

From: A personalized, web-based breast cancer decision making application: a pre-post survey

 

Used tool

(N = 255)a

Did not use tool

(N = 35)a

Total

(N = 290)a

Age in years (mean [SD])

56.8 (11.8)

60.6 (12.0)

57.2 (11.8)

Race

 White

236 (92.5%)

31 (88.6%)

267 (92.1%)

 African American

1 (0.4%)

1 (2.9%)

2 (0.7%)

 American Indian/Alaskan Native

4 (1.6%)

0 (0.0%)

4 (1.4%)

 Asian

7 (2.7%)

2 (5.7%)

9 (3.1%)

 Other

2 (0.8%)

0 (0.0%)

2 (0.7%)

 Unknown or choose not to disclose

5 (2.0%)

1 (2.9%)

6 (2.1%)

Education

 Some high school (HS), did not graduate

1 (0.4%)

0 (0.0%)

1 (0.3%)

 HS graduate or GED

35 (13.8%)

12 (35.3%)

47 (16.3%)

 Some college or 2-year degree

81 (31.9%)

8 (23.5%)

89 (30.9%)

 4-year college graduate

69 (27.2%)

8 (23.5%)

77 (26.7%)

 Post graduate studies

68 (26.8%)

6 (17.6%)

74 (25.7%)

Preferred decision making approach

 I make decision

5 (2.2%)

3 (8.6%)

8 (3.0%)

 I make decision & consider doctor’s opinion

68 (29.4%)

11 (31.4%)

79 (29.7%)

 Shared decision making

144 (62.3%)

18 (51.4%)

162 (60.9%)

 Doctor makes decision & considers my opinion

11 (4.8%)

3 (8.6%)

14 (5.3%)

 Doctor makes decision

3 (1.3%)

0 (0.0%)

3 (1.1%)

Breast cancer stage

 Stage 0

35 (16.2%)

3 (12.0%)

38 (15.8%)

 Stage I

97 (44.9%)

13 (52.0%)

110 (45.6%)

 Stage II

66 (30.6%)

5 (20.0%)

71 (29.5%)

 Stage III

18 (8.3%)

4 (16.0%)

22 (9.1%)

Breast cancer laterality

 Bilateral

11 (4.9%)

4 (14.8%)

15 (5.9%)

 Unilateral

215 (95.1%)

23 (85.2%)

238 (94.1%)

Breast cancer type

 Bilateral (discordant)

6 (2.7%)

1 (3.7%)

7 (2.8%)

 Ductal carcinoma in situ

39 (17.3%)

3 (11.1%)

42 (16.7%)

 Invasive

180 (80.0%)

23 (85.2%)

203 (80.6%)

Hormonal therapyb

 Adjuvant

139/226 (61.5%)

17/27 (63.0%)

156/253 (61.7%)

 Neoadjuvant

13/226 (5.8%)

0/27 (0.0%)

13/253 (5.1%)

Chemotherapyb

 Adjuvant

36/226 (15.9%)

6/27 (22.2%)

42/253 (16.6%)

 Neoadjuvant

13/226 (5.8%)

0/27 (0.0%)

13/253 (5.1%)

Radiation therapyb

133/226 (58.8%)

18/27 (66.7%)

151/253 (59.7%)

Surgeryb

 Lumpectomy

123/226 (54.4%)

14/27 (51.9%)

137/253 (54.2%)

 Unilateral mastectomy

44/226 (19.5%)

4/27 (14.8%)

48/253 (19.0%)

 Bilateral mastectomy

59/226 (26.1%)

8/27 (29.6%)

67/253 (26.5%)

 Reconstructive surgery

75/226 (33.2%)

6/27 (22.2%)

81/253 (32.0%)

  1. aFrequencies not adding to column total indicate missing data (not included in denominator for percentages)
  2. bCategories not mutually exclusive (denominators provided)